Cochrane · systematic review · CD009481
Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for psoriasis
Chen, X, Yang, M, Cheng, Y, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
SkinAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
20
current version
GRADE rated
8
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 12 · 60%Very low 0 · 0%Low 8 · 40%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
NB‐UVB compared with oral PUVA for chronic plaque psoriasis
Population: People with chronic plaque psoriasis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Participant‐rated global improvement NB‐UVB vs oral PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
Percentage of participants reaching PASI 75 NB‐UVB vs oral PUVA | RR 0.91 [0.63, 1.32] | 1 study · 51 participants | Low Downgraded: risk of bias, imprecision |
Withdrawal due to side‐effects NB‐UVB vs oral PUVA | RR 0.71 [0.2, 2.54] | 3 studies · 247 participants | Low Downgraded: risk of bias, imprecision |
Clearance rate NB‐UVB vs oral PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
NB‐UVB compared with bath PUVA for chronic plaque psoriasis
Population: People with chronic plaque psoriasis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Participant‐rated global improvement NB‐UVB vs bath PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
Percentage of participants reaching PASI 75 NB‐UVB vs bath PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
Withdrawal due to side‐effects NB‐UVB vs bath PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
Clearance rate NB‐UVB vs bath PUVA | RR 1.79 [0.46, 6.91] | 2 studies · 92 participants | Low Downgraded: risk of bias, imprecision |
NB‐UVB compared with topical PUVA for palmoplantar psoriasis
Population: People with palmoplantar psoriasis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Participant‐rated global improvement NB‐UVB vs topical PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
Percentage of participants reaching PASI 75 NB‐UVB vs topical PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
Withdrawal due to side‐effects NB‐UVB vs topical PUVA | no estimate extracted | 0 studies · 0 participants | Ungraded |
Clearance rate NB‐UVB vs topical PUVA | RR 0.09 [0.01, 1.56] | 1 study · 50 participants | Low Downgraded: risk of bias, imprecision |
NB‐UVB plus retinoid compared with PUVA plus retinoid for chronic plaque or guttate psoriasis
Population: People with chronic plaque or guttate psoriasis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Participant‐rated global improvement NB‐UVB plus retinoid vs PUVA plus retinoid | no estimate extracted | 0 studies · 0 participants | Ungraded |
Percentage of participants reaching PASI 75 NB‐UVB plus retinoid vs PUVA plus retinoid | RR 0.89 [0.59, 1.35] | 1 study · 60 participants | Low Downgraded: risk of bias, imprecision |
Withdrawal due to side‐effects NB‐UVB plus retinoid vs PUVA plus retinoid | no estimate extracted | 0 studies · 0 participants | Ungraded |
Clearance rate NB‐UVB plus retinoid vs PUVA plus retinoid | RR 0.93 [0.79, 1.1] | 2 studies · 90 participants | Low Downgraded: risk of bias, imprecision |
NB‐UVB compared with selective BB‐UVB for chronic plaque psoriasis
Population: People with chronic plaque psoriasis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Participant‐rated global improvement NB‐UVB vs selective BB‐UVB | no estimate extracted | 0 studies · 0 participants | Ungraded |
Percentage of participants reaching PASI 75 NB‐UVB vs selective BB‐UVB | no estimate extracted | 0 studies · 0 participants | Ungraded |
Withdrawal due to side‐effects NB‐UVB vs selective BB‐UVB | RR 3 [0.32, 27.87] | 1 study · 100 participants | Low Downgraded: risk of bias, imprecision |
Clearance rate NB‐UVB vs selective BB‐UVB | RR 1.4 [0.92, 2.13] | 1 study · 100 participants | Low Downgraded: risk of bias, imprecision |